产品中心Products Resources
联系我们CONTACT US
-
400 179 0116
24小时服务热线
跨年狂欢 单套1080,3套起1040/套,5套起980/套
货号:活动日期2025.12.15-2026.1.15
价格: ¥单套1080,3套起1040/套,5套起980/套
产品介绍/Products Introduction

跨年狂欢 单套1080,3套起1040/套,5套起980/套,完美替代所有进口低血清内皮细胞培养系列,ECGM内皮细胞培养基2024年发表使用文献达10篇以上,国内现货,1-2天左右可以发,试用装付邮即送,购买正装后退运费!点击链接申请试用 http://www.ldraft.com/qdtrial/1.html
内皮细胞培养基是一种低血清内皮细胞完全培养基,适合血管内皮细胞和永生化的内皮细胞株。
内皮细胞培养基经10种人各部位的内皮细胞的测试和优化,经无菌,无支原体,无内毒素检测,添加肝素,内皮生长因子,胰岛素,抗氧化剂,皮质醇等组分,为了实现细胞的正常的新陈代谢过程,培养基尽量减少生长刺激的因子组分。
其中
P1001-NG是无糖的培养基系列,
P1001-NL是无谷氨酰胺的培养基系列,
P1001-M是小鼠内皮培养系列,
P1001-R是大鼠内皮系列
培养基配方:
基础培养基:500ml(P1000),细胞生长因子(ECGS):5ml (P1002),胎牛血清:25ml(SD0200),
G/A:5ml(SD0038)
培养基优势:
1.BBB实验首选共培养培养基,适用于大部分血管内皮细胞的培养,扩增和传代,还分大小鼠和人源的哦。
2.细化分类,分为人源,大鼠源,小鼠源内皮培养系列。
3.大罐过滤灌装,采用人工称量后再进行自动称量,保持各化学组分均衡反应与充分结合,保质期一年,避免存放过久氨基酸降解及激素变性。
4.采用小分子化合物抑制杂细胞生长,添加促内皮生长因子让内皮细胞生长。
5.经60多种内皮细胞验证生长速度;可平替进口品牌。
6.低血清组分减少血清在细胞内的干扰。
7.套装发货,配制简单,使用方便。
声明:产品仅科研使用。
参考文献/Publications
1. PMID: 35369032 nternational Journal of Nanomedicine 2022:17 1397–1408 Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis
2. Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy.ACS Nano 2022, 16, 7, 11325–11337
https://doi.org/10.1021/acsnano.2c04982
3.Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy Investigative Ophthalmology & Visual Science July 2022, Vol.63, 9
https://pubmed.ncbi.nlm.nih.gov/35816041
4. himpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration.Published:September 15, 2023
https://doi.org/10.1016/j.isci.2023.10793
5. Potential role of nitrogen in spore dispersal and infection of Paraphysoderma sedebokerense, a fungal parasite of Haematococcus pluvialis Received 2 April 2021
https://doi.org/10.1016/j.algal.2021.102552
6. Injectable Living Probiotic Dressing Built by Droplet-Based Microfluidics and Photo-Cross-Linking to Prevent Pathogenic Infection and Promote Wound Repair.16 October 2023
https://doi.org/10.1002/adhm.202302423
7. Single‑cell transcriptomics reveal the crosstalk between plate- 1 let-associated TRAF4high endothelial cell subpopulation and 2 tumor microenvironment in colorectal cancer
https://doi.org/10.21203/rs.3.rs-4506500/v1
8. Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration
https://doi.org/10.1016/j.isci.2023.107939
9. LncRNA-MM2P regulates retinal neovascularization through M2 macrophage polarization author links open overlay
https://doi.org/10.1016/j.exer.2024.110072
10. Haixiang Zhou, Bingyan Li, Zicong Wang , Yuting Cai , Shigeo Yoshida , Yedi Zhou, Yun Li,HO-1-mediated ferroptosis regulates retinal neovascularization via the COX2/VEGFA axis
https://doi.org/10.1016/j.freeradbiomed.2024.11.017
11. Shen, W., Han, G., Yu, L., Yang, S., Li, X., Zhang, W., & Pei, P. (2022). Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis. International Journal of Nanomedicine, 17, 1397–1408
https://doi.org/10.2147/IJN.S359156
12. Exploring PU.1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis-Induced Peritoneal Fibrosis
https://doi.org/10.1096/fj.202500305RR
13. Biomimetic nanoparticles facilitate homologous targeting and radiosensitivity in glioblastoma cells
https://doi.org/10.1016/j.mtnano.2025.100676
14. M2 Macrophage-Derived Migrasomes Mediate Ischaemia-Induced Retinal Neovascularization by Targeting TREM2,First published: 31 October 2025
https://doi.org/10.1002/jev2.70180






